NCT03905811View on ClinicalTrials.gov

A Pilot Study of Terazosin for Parkinson's Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 24, 2019

Primary Completion Date

June 5, 2020

Study Completion Date

November 18, 2020

Conditions
Parkinson Disease
Interventions
DRUG

Terazosin 5 MG

5 milligrams by mouth daily at bedtime

DRUG

Placebo oral capsule

1 capsule by mouth daily at bedtime

Trial Locations (1)

52242

University of Iowa Hospitals and Clinics, Iowa City

All Listed Sponsors
collaborator

University of Iowa

OTHER

lead

Jordan Schultz

OTHER

NCT03905811 - A Pilot Study of Terazosin for Parkinson's Disease | Biotech Hunter | Biotech Hunter